Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: Experience from a single academic center

Clinics

Volumn 67, Issue SUPPLEMENT, 2012, Pages 131-139

  Montenegro, Fabio Luiz de Menezes ^a   Lourenço Jr , Delmar Muniz ^a   Tavares, Marcos Roberto ^a   Arap, Sergio Samir ^a   Nascimento, Climerio Pereira ^a   Neto, Ledo Mazzei Massoni ^a   D'Alessandro, André ^a   Toledo, Rodrigo Almeida ^a   Coutinho, Flávia Lima ^a   Brandão, Lenine Garcia ^a   e Silva Filho, Gilberto de Britto ^a   Cordeiro, Anói Castro ^a   Toledo, Sergio Pereira Almeida ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hypercalcemia; Hyperparathyroidism; MEN1; Parathyroid glands; Parathyroid neoplasms; Parathyroidectomy

Indexed keywords

EID: 84863945130     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(Sup01)22     Document Type: Review

References (72)

1. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86(12):5658-71, http://dx.doi.org/10.1210/jc.86.12.5658.
2. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer. 2005;5(2):367-75, http://dx.doi.org/10.1038/nrc1610.
3. Lourenço DM Jr, Toledo RA, Coutinho FL, Margarido LC, Siqueira SA, dos Santos MA, et al. The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1. Clinics. 2007;62(4):465-76, http://dx.doi.org/10.1590/S1807-59322007000400014.
4. Lips CJM, Dreijerink K, Links TP, Höppener JWM. Multiple endocrine neoplasia type 1. Exp Rev Endocrinol Metab. 2009;4(4):371-88, http://dx.doi.org/10.1586/eem.09.22.
5. Falchetti A, Marini F, Luzi E, Giusti F, Cavalli L, Cavalli T, Brandi ML. Multiple endocrine neoplasia type 1 (MEN1): Not only inherited endocrine tumors. Genet Med. 2009;11(12):825-35, http://dx.doi.org/10.1097/GIM.0b013e3181be5c97.
6. Lourenço DM Jr, Toledo RA, Mackowiak II, Coutinho FL, Cavalcanti MG, Correia-Deur JE, et al. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile. Eur J Endocrinol. 2008;159(3):259-74, http://dx.doi.org/10.1530/EJE-08-0153.
7. Lourenço DM Jr, Coutinho FL, Toledo RA, Montenegro FL, Correia-Deur JE, Toledo SP. Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. J Bone Miner Res. 2010;25(11):2382-91, http://dx.doi.org/10.1002/jbmr.125.
8. Arnalsteen LC, Alesina PF, Quiereux JL, Farrel SG, Patton FN, Carnaille BM, et al. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2002;132(6):1119-24, http://dx.doi.org/10.1067/msy.2002.128607.
9. Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, et al. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res. 2009;24(8):1404-10, http://dx.doi.org/10.1359/jbmr.090304.
10. Toledo RA, Lourenço DM, Coutinho FL, Quedas E, Mackowiack I, Machado MC, et al. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2007;67(3):377-84, http://dx.doi.org/10.1111/j.1365-2265.2007.02895.x.
11. Lourenço DM Jr, Coutinho FL, Toledo RA, Gonçalves TD, Montenegro FL, Toledo SP. Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1. Clinics. 2012;67(S1):99-108, http://dx.doi.org/10.6061/clinics/2012(Sup01)17.
12. Heath H 3rd. Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Miner Res. 1991;6(Suppl 2):S63-70.
13. Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):340-50, http://dx.doi.org/10.1210/jc.2008-1758.
14. Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2005;90(1):135-41, http://dx.doi.org/10.1210/jc.2004-0842.
15. Falchetti A, Cilotti A, Vaggelli L, Masi L, Amedei A, Cioppi F, et al. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. Nat Clin Pract Endocrinol Metab. 2008;4(6):351-7, http://dx.doi.org/10.1038/ncpendmet0888.
16. Moyes VJ, Monson JP, Chew SL, Akker SA. Clinical use of cinacalcet in MEN1 hyperparathyroidism. Int J Endocrinol. 2010;2010:906163.
17. Veldman MW, Reading CC, Farrell MA, Mullan BP, Wermers RA, Grant CS, et al. Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1. AJR Am J Roentgenol. 2008;191(6): 1740-4, http://dx.doi.org/10.2214/AJR.07.3431.
18. Kovatcheva RD, Vlahov JD, Shinkov AD, Borissova AM, Hwang JH, Arnaud F, et al. High-intensity focused ultrasound to treat primary hyperparathyroidism: a feasibility study in four patients. Am J Roentgenol. 2010;195(4):830-5, http://dx.doi.org/10.2214/AJR.09.3932.
19. Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab. 2006;2(9):494-503, http://dx.doi.org/10.1038/ncpendmet0265.
20. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93(9):3462-70, http://dx.doi.org/10.1210/jc.2007-1215.
21. Bilezikian JP, Potts JT Jr, Fuleihan Gel H, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87(12):5353-61, http://dx.doi.org/10.1210/jc.2002-021370.
22. Bilezikian JP, Khan A, Arnold A, Brandi ML, Brown E, Bouillon R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335-9, http://dx.doi.org/10.1210/jc.2008-1763.
23. Hellman P, Skogseid B, Oberg K, Juhlin C, Akerström G, Rastad J. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery. 1998;124(6):993-9, http://dx.doi.org/10.1016/S0039-6060(98)70040-6.
24. Hubbard JG, Sebag F, Maweja S, Henry JF. Primary hyperparathyroidism in MEN 1-how radical should surgery be? Langenbecks Arch Surg. 2002;386(8):553-7, http://dx.doi.org/10.1007/s00423-002-0275-0.
25. Burgess JR, Giles N, Shepherd JJ. Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2001;55(5):689-93, http://dx.doi.org/10.1046/j.1365-2265.2001.01348.x.
26. Lim LC, Tan MH, Eng C, Teh BT, Rajasoorya RC. Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention. J Intern Med. 2006;259(4):428-32, http://dx.doi.org/10.1111/j.1365-2796.2006.01619.x.
27. Montenegro FLM, Neves MC, Lourenço Jr DM, Arap SS, Nascimento Jr CP, Toledo SPA, et al. Thymectomy in the surgical approach to hyperparathyroidism in type 1 multiple endocrine neoplasia. Rev Bras Cir Cab Pesc. 2010;39(3):174-8.
28. Shepherd JJ. The natural history of multiple endocrine neoplasia type 1: highly uncommon or highly unrecognized? Arch Surg. 1991;126(8):935-52, http://dx.doi.org/10.1001/archsurg.1991.01410320017001.
29. Boguszewski CL, Bianchet LC, Raskin S, Nomura LM, Borba LA, Cavalcanti TC. Application of genetic testing to define the surgical approach in a sporadic case of multiple endocrine neoplasia type 1. Arq Bras Endocrinol Metabol. 2010;54(8):705-10, http://dx.doi.org/10.1590/S0004-27302010000800007.
30. Waldmann J, López CL, Langer P, Rothmund M, Bartsch DK. Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. Br J Surg. 2010;97(10):1528-34, http://dx.doi.org/10.1002/bjs.7154.
31. Westerdahl J, Bergenfelz A. Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: unobserved multiple endocrine neoplasia as an explanation. Arch Surg. 2006;141(6):589-94, http://dx.doi.org/10.1001/archsurg.141.6.589.
32. Shih RY, Fackler S, Maturo S, True MW, Brennan J, Wells D. Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation. Endocr Pract. 2009;15(6):567-72, http://dx.doi.org/10.4158/EP09045.CRR1.
33. Cordeiro AC, Montenegro FL, Kulcsar MA, Dellanegra LA, Tavares MR, Michaluart P Jr, et al. Parathyroid carcinoma. Am J Surg. 1998;175(1):52-5, http://dx.doi.org/10.1016/S0002-9610(97)00228-6.
34. Montenegro FL, Tavares MR, Durazzo MD, Cernea CR, Cordeiro AC, Ferraz AR. Clinical suspicion and parathyroid carcinoma management. Sao Paulo Med J. 2006;124(1):42-4, http://dx.doi.org/10.1590/S1516-31802006000100009.
35. Montenegro FM, Brandão LG, Ferreira GF, Lourenço DM Jr, Martin RM, Cunha-Neto MB, et al. Transitory increase in creatinine levels after parathyroidectomy: evidence of another action of the parathyroid glands? Arq Bras Endocrinol Metabol. 2011;55(4):249-55, http://dx.doi.org/10.1590/S0004-27302011000400002.
36. Teh BT, McArdle J, Chan SP, Menon J, Hartley L, Pullan P, et al. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine (Baltimore). 1997;76(1):21-9, http://dx.doi.org/10.1097/00005792-199701000-00002.
37. Goudet P, Murat A, Cardot-Bauters C, Emy P, Baudin E, du Boullay Choplin H, et al. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines). World J Surg. 2009;33(6):1197-207, http://dx.doi.org/10.1007/s00268-009-9980-y.
38. Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88(3):1066-81, http://dx.doi.org/10.1210/jc.2002-021314.
39. Powell AC, Alexander HR, Pingpank JF, Steinberg SM, Skarulis M, Bartlett DL, et al. The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. Surgery. 2008;144(6):878-83, http://dx.doi.org/10.1016/j.surg.2008.08.031.
40. Wells Jr SA, Gunnells JC, Shelburne JD, Schneider AB, Sherwood LM. Transplantation of the parathyroid glands in man: clinical indications and results. Surgery. 1975;78(1):34-44.
41. Wells Jr SA, Ellis GJ, Gunnells JC, Schneider AB, Sherwood LM. Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med. 1976;295(2):57-62, http://dx.doi.org/10.1056/NEJM197607082950201.
42. Wells Jr SA, Farndon JR, Dale JK, Leight GS, Dilley WG. Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg. 1980;192(4):451-8, http://dx.doi.org/10.1097/00000658-198010000-00003.
43. Malmaeus J, Benson L, Johansson H, Ljunghall S, Rastad J, Akerström G, et al. Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: choice of surgical procedure. World J Surg. 1986;10:668-72, http://dx.doi.org/10.1007/BF01655552.
44. Burgess JR, David R, Parameswaran V, Greenaway TM, Shepherd JJ. The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 1998;133(2):126-9, http://dx.doi.org/10.1001/archsurg.133.2.126.
45. Lambert LA, Shapiro SE, Lee JE, Perrier ND, Truong M, Wallace MJ, et al. Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg. 2005;140(4):374-82, http://dx.doi.org/10.1001/archsurg.140.4.374.
46. Hubbard JG, Sebag F, Maweja S, Henry JF. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 2006;141(3):235-9, http://dx.doi.org/10.1001/archsurg.141.3.235.
47. Elaraj DM, Skarulis MC, Libutti SK, Norton JA, Bartlett DL, Pingpank JF, et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134(6):858-64, http://dx.doi.org/10.1016/S0039-6060(03)00406-9.
48. Tonelli F, Marcucci T, Fratini G, Tommasi MS, Falchetti A, Brandi ML. Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Ann Surg. 2007;246(6):1075-82, http://dx.doi.org/10.1097/SLA.0b013e31811f4467.
49. Tonelli F, Marcucci T, Giudici F, Falchetti A, Brandi ML. Surgical approach in hereditary hyperparathyroidism. Endocr J. 2009;56(7):827-41, http://dx.doi.org/10.1507/endocrj.K09E-204.
50. Tonelli F, Giudici F, Cavalli T, Brandi ML. Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: total versus partial parathyroidectomy. Clinics. 2012;67(S1):155-160, http://dx.doi.org/10.6061/clinics/2012(Sup01)26.
51. Hellman P, Skogseid B, Juhlin C, Akerström G, Rastad J. Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1. World J Surg. 1992;16(4):718-22, http://dx.doi.org/10.1007/BF02067367.
52. Schreinemakers JM, Pieterman CR, Scholten A, Vriens MR, Valk GD, Borel Rinkes IH. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg. 2011;35(9):1993-2005, http://dx.doi.org/10.1007/s00268-011-1068-9.
53. Piecha G, Chudek J, Wie{ogonek}cek A. Primary hyperparathyroidism in patients withmultiple endocrine neoplasia type 1. Int J Endocrinol. 2010;2010:928383.
54. Montenegro FLM, Smith RB, Arap SS, Turcano R, Michaluart Jr P, Tavares MR, et al. Teaching of parathyroid surgery and proposal of a complexity stratifying scale. Rev Bras Cir Cabeça Pescoço. 2008;37(1):71-5.
55. Montenegro FLM, Brandão LG, Arap SS, Durazzo MD, Nascimento Jr CP, Santos SRCL, et al. Parathyroidectomy as a model of learning evaluation of surgery residents: initial results of a prospective study. Rev Bras Cir Cab Pesc. 2009;38(4):4-9.
56. Goudet P, Cougard P, Vergès B, Murat A, Carnaille B, Calender A, et al. Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group. World J Surg. 2001;25(7):886-90, http://dx.doi.org/10.1007/s00268-001-0046-z.
57. Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg. 2010;34(2):249-55.
58. Coutinho FL, Lourenço DM Jr, Toledo RA, Montenegro FL, Correia-Deur JE, Toledo SP. Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. Clin Endocrinol (Oxf). 2010;72(4):462-8, http://dx.doi.org/10.1111/j.1365-2265.2009.03672.x.
59. Coutinho FL, Lourenço DM Jr, Toledo RA, Montenegro FL, Toledo SP. Post-surgical follow up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1. Clinics. 2012;67(S1):169-72, http://dx.doi.org/10.6061/clinics/2012(Sup01)28.
60. Damiani D, Aguiar CH, Bueno VS, Montenegro FL, Koch VH, Cocozza AM, et al. Primary hyperparathyroidism in children: patient report and review of the literature. J Pediatr Endocrinol Metab. 1998;11(1):83-6, http://dx.doi.org/10.1515/JPEM.1998.11.1.83.
61. Toledo RA, Sekiya T, Longuini VC, Coutinho FL, Lourenço DM Jr, Toledo SP. Narrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in Brazil. Clinics. 2012;67(S1):3-6, http://dx.doi.org/10.6061/clinics/2012(Sup01)02.
62. Montenegro F, Martin RM, Lourenço Jr DM, Arap SS, Nascimento Jr CP, Brandão LG. Transient change of glomerular function rate after parathyroidectomy is not dependent on preoperative renal function. Rev Bras Cir Cab Pesc. 2010;39(4):99-102.
63. Barreira CE, Cernea CR, Brandão LG, Custódio MR, Caldini ET, de Menezes Montenegro FL. Effects of time on ultrastructural integrity of parathyroid tissue before cryopreservation. World J Surg. 2011;35(11): 2440-4, http://dx.doi.org/10.1007/s00268-011-1261-x.
64. de Menezes Montenegro FL, Custódio MR, Arap SS, Reis LM, Sonohara S, et al. Successful implant of long-term cryopreserved parathyroid glands after total parathyroidectomy. Head Neck. 2007;29(3):296-300, http://dx.doi.org/10.1002/hed.20506.
65. Caliseo CT, Santos SR, Nascimento CP Jr, Arap SS, Brandão LG, Montenegro FL. Functional results of parathyroid autotransplantation in one single pocket for treatment of secondary hyperparathyroidism. Rev Col Bras Cir. 2011;38(2):85-9, http://dx.doi.org/10.1590/S0100-69912011000200003.
66. Tonelli F, Spini S, Tommasi M, Gabbrielli G, Amorosi A, Brocchi A, et al. Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism. World J Surg. 2000;24(5):556-62, http://dx.doi.org/10.1007/s002689910091.
67. Montenegro FL, Tavares MR, Cordeiro AC, Ferraz AR, Ianhez LE, Buchpigel CA. Intrathyroidal supernumerary parathyroid gland in hyperparathyroidism after renal transplantation. Nephrol Dial Transplant. 2007;22(1):293-5, http://dx.doi.org/10.1093/ndt/gfl503.
68. Schneider R, Waldmann J, Ramaswamy A, Fernández ED, Bartsch DK, Schlosser K. Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg. 2011;35(6):1260-5, http://dx.doi.org/10.1007/s00268-011-1079-6.
69. Falchetti A, Brandi ML. Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue? J Clin Endocrinol Metab. 2009;94(5):1518-20, http://dx.doi.org/10.1210/jc.2009-0494.
70. Montenegro FLM, Smith RB, Castro IV, Tavares MR, Cordeiro AC, Ferraz AR. Association of papillary thyroid carcinoma and hyperparathyroidism. Rev Col Bras Cir. 2005;32:115-9, http://dx.doi.org/10.1590/S0100-69912005000300003.
71. Stålberg P, Carling T. Familial parathyroid tumors: diagnosis and management. World J Surg. 2009;33(11):2234-43, http://dx.doi.org/10.1007/s00268-009-9924-6.
72. Salmeron MD, Gonzelez JM, Sancho insenser J, Goday A, Perez NM, Zambudio AR, et al. Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1. World J Surg. 2010;34(6):1325-31.